Use of PPAR.gamma. agonists for inhibition of inflammatory cytokine production
US5925657A · kind A · utility
55Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 18, 1997 |
| Grant date | Jul 20, 1999 |
| Priority date | — |
| Expiry date | Jun 18, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/427
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are methods for reducing or preventing cytokine production associated with an inflammatory response, involving administering to a mammal a therapeutically-effective amount of a thiazolidinedione PPAR.gamma. agonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.